elliptinium has been researched along with Carcinoma, Hepatocellular in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (75.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Habraken, Y; Laval, F | 1 |
| Alberici, GF; Bohuon, C; Dessaux, JJ; Fournier, J; Gros, P; Manil, L; Mondesir, JM; Pallardy, M | 1 |
| Droz, JP; Rougier, P; Ychou, M | 1 |
| Bourel, M; Brissot, P; Delamaire, D; Deugnier, Y; Jouanolle, H; Lhéry, D; Simon, M | 1 |
2 trial(s) available for elliptinium and Carcinoma, Hepatocellular
| Article | Year |
|---|---|
[Failure of elliptinium acetate in the treatment of unresectable hepatocarcinoma (phase II trial)].
Topics: Aged; Alkaloids; Antineoplastic Agents; Carcinoma, Hepatocellular; Clinical Trials as Topic; Ellipticines; Female; Humans; Liver Neoplasms; Male; Middle Aged | 1988 |
[Randomized trial of elliptinium acetate and tamoxifen in the treatment of inoperable hepatocellular carcinoma].
Topics: Adult; Aged; Alkaloids; Carcinoma, Hepatocellular; Drug Evaluation; Ellipticines; Female; Humans; Liver Neoplasms; Male; Middle Aged; Random Allocation; Tamoxifen | 1986 |
2 other study(ies) available for elliptinium and Carcinoma, Hepatocellular
| Article | Year |
|---|---|
Enhancement of 1,3-bis(2-chloroethyl)-1-nitrosourea resistance by gamma-irradiation or drug pretreatment in rat hepatoma cells.
Topics: Animals; Antineoplastic Agents; Carcinoma, Hepatocellular; Carmustine; Cisplatin; Combined Modality Therapy; Dose-Response Relationship, Radiation; Drug Resistance; Drug Synergism; Ellipticines; Gamma Rays; Liver Neoplasms; Methyltransferases; O(6)-Methylguanine-DNA Methyltransferase; Rats; Time Factors; Tumor Cells, Cultured | 1991 |
Conjugates of elliptinium acetate with mouse monoclonal anti-alpha-fetoprotein antibodies or Fab fragments: in vitro cytotoxic effects upon human hepatoma cell lines.
Topics: Alkaloids; alpha-Fetoproteins; Antibodies, Monoclonal; Antineoplastic Agents; Carcinoma, Hepatocellular; Cell Line; Chemical Phenomena; Chemistry; DNA, Neoplasm; Drug Combinations; Ellipticines; Humans; Immunoglobulin Fab Fragments; Liver Neoplasms | 1988 |